Physician profile
Ian Parker
NPI 1306262712
$73,745.33
in general payments reported to CMS, 2019-2025
32 companies · $13K in 2025
The $13K reported for 2025 was more than what 84% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,902 · 2021: $8,780 · 2022: $14K · 2023: $13K · 2024: $13K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $20K · Food and Beverage: $17K · Consulting Fee: $1,000 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,228.42 |
| Food and Beverage | $17,294.72 |
| Consulting Fee | $1,000.00 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $28,879.74 | 2019-2025 | Ensite, Ensite Precision, Na |
| Medtronic, INC. | $24,728.38 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan, Arctic Front Advance |
| Boston Scientific Corporation | $8,208.79 | 2019-2025 | General - Therapies, Rhythmia Mapping System, Farapulse |
| Atricure, INC. | $4,469.45 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic Vascular, INC. | $3,263.70 | 2019-2020 | |
| Pfizer INC. | $715.52 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $586.84 | 2020-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $356.17 | 2022-2024 | Optimizer, Optimizer |
| Philips North America LLC | $326.84 | 2021-2023 | |
| Amgen INC. | $268.29 | 2019-2024 | Repatha |
| Irhythm Technologies, INC. | $249.59 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $238.94 | 2019 | |
| Biosense Webster, INC. | $214.70 | 2021-2025 | Carto 3 |
| Alnylam Pharmaceuticals INC. | $196.99 | 2020-2025 | Amvuttra, Onpattro |
| Stereotaxis INC | $154.28 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $144.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $122.28 | 2023-2024 | |
| Janssen Scientific Affairs, LLC | $120.72 | 2021 | |
| Kestra Medical Technology Services, INC. | $103.51 | 2023-2024 | Assure Wcd |
| Baxter Healthcare | $68.33 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $60.32 | 2019-2023 | Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.13 | 2023-2024 | Jardiance |
| Cardiva Medical, INC. | $31.17 | 2022 | |
| Merck Sharp & Dohme LLC | $30.47 | 2022-2024 | Verquvo |
| Innovation Technologies INC | $24.94 | 2023 | Irrisept |
| Sanofi-Aventis U.S. LLC | $24.84 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $24.63 | 2024 | |
| Viiv Healthcare Company | $22.41 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.52 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.24 | 2019 | |
| Lantheus Medical Imaging, INC. | $15.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.